[1] 刘东锋,张峰.PET/CT多种示踪剂显像在肝细胞癌诊断中的研究进展[J].功能与分子医学影像学(电子版),2017,6(2):1219-1222.
[2] 张浩.肝癌肝动脉栓塞用载药微球的研究现状及进展[J].医学临床研究,2017,34(2):341-344.
[3] Zheng H, Pomyen Y, Hernandez M O, et al. Single cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma[J].Hepatology,2018,68(1):127-140.
[4] Yagci T, Cetin M, Ercin P B. Cancer stem cells in hepatocellular carcinoma[J]. Journal of Gastrointestinal Cancer, 2017, 48(3):241-245.
[5] 丁芳, 顾红梅, 葛涌钱. 磁共振DWI及R2成像对小肝癌与硬化结节的鉴别诊断价值[J]. 临床放射学杂志, 2018,(11):1844-1847.
[6] 白秀艳,孙玉,侯杰,等.钆塞酸二钠增强磁共振成像对肝脏局灶性病变的诊断价值分析[J].磁共振成像,2018,9(2):102-107.
[7] 苏赞瑞,黄运福,林建军,等.DSA和钆塞酸二钠增强MRI对肝癌术后复发微小病灶诊断的比较研究[J].介入放射学杂志,2017,26(6):559-563.
[8] 佟晶, 卑贵光, 李玉泽,等. 钆塞酸二钠增强MR与增强CT在肝脏局灶性病变诊断中的对比研究[J]. 中国临床医学影像杂志, 2017,28(9):642-646.
[9] Zhang H Y, Luo S Q. Strategies for the management of hepatocellular carcinoma recommended by the American Association for the Study of Liver Diseases[J]. Chinese Journal of Hepatology, 2006, 14(7):556-557.
[10] 潘音桦,黄瑜,李杰华.乳腺癌的超声与增强MRI应用ROC曲线对比研究[J].中国医学创新,2017,14(11):37-40.
[11] 于朝霞,赵伟,刘晓明,等.超声造影对于肝硬化背景下小肝癌的早期诊断价值[J].中国医疗设备,2017,32(10):62-64.
[12] 季如宁,刘可夫,王滢,等.CT与MRI对肝硬化背景下小肝癌检出率的比较[J].现代生物医学进展,2017,17(29):5732-5735.
[13] 钟熹,汤日杰,李建生,等.MRI纹理分析鉴别诊断肝硬化背景下小肝癌与增生结节[J].中国医学影像技术,2018,34(7):1041-1045.
[14] 沈莉红.超声对肝硬化再生结节和小肝癌的诊断及鉴别诊断价值研究[J].中国卫生标准管理,2017,8(7):107-108.
[15] 沈祥春.核磁共振成像在肝硬化再生结节和小肝癌中的鉴别诊断比较[J].影像研究与医学应用,2018,2(9):97-98.
[16] 刘冬.磁共振肝胆特异性对比剂Gd-EOB-DTPA在肝胆系统病变中的应用价值[D].苏州:苏州大学,2018.
[17] 阮聪华.肝脏MRI动态增强扫描:Gd-DTPA与Gd-EOB-DTPA的个体内对照研究[J].临床合理用药杂志,2018,11(14):92-93.
[18] Huang M Q, Liao B, Xu P, et al. Prediction of microvascular invasion in hepatocellular carcinoma:preoperative Gd-EOB-DTPA-dynamic enhanced MRI and histopathological correlation[J]. Contrast Media & Molecular Imaging,2018:Article ID 9674565.
[19] Juluru K, Talal A H, Yantiss R K, et al. Diagnostic accuracy of intracellular uptake rates calculated using dynamic Gd-EOB-DTPA-enhanced MRI for hepatic fibrosis stage[J]. Journal of Magnetic Resonance Imaging,2017,45(4):1177-1185.
[20] 戴志军,吴小红,郝宏毅.Gd-EOB-DTPA增强MRI对肝硬化肝功能评价的应用[J].宁夏医学杂志,2017,39(8):691-693.
[21] 熊廷伟,龚明福,廖翠薇,等.Gd-EOB-DTPA增强MRI对肝硬化背景下小肝细胞癌的诊断价值[J].检验医学与临床,2017,14(23):3441-3443.
[22] 富鹏.Gd-EOB-DTPA增强MRI对肝硬化病理分级的诊断价值研究[J].中国CT和MRI杂志,2018,16(12):101-103.
[23] 王铭洁,王峥,杨伟,等. 3.0T MRI联合带厚度指标对子宫腺肌症的诊断价值及ROC曲线分析[J].河北医药,2018,40(9):61-63,68.
[24] 郑桦,符孔,李传资,等. DWI和DCE-MRI鉴别不同乳腺炎性疾病类型的价值研究[J].河北医药,2018,40(21):38-41.
[25] 许永生,刘海峰,黎金葵,等.Gd-EOB-DTPA增强MRI鉴别肝脏良恶性病灶的临床应用价值[J].磁共振成像,2018,9(7):506-511.
[26] Guo J, Seo Y, Ren S, et al. Diagnostic performance of contrastenhanced multidetector computed tomography and gadoxetic acid disodium-enhanced magnetic resonance imaging in detecting hepatocellular carcinoma:direct comparison and a meta-analysis[J].Abdominal Radiology,2016,41(10):1960-1972. |